Hijacking a small plasmid to confer high-level resistance to aztreonam-avibactam and ceftazidime-avibactam

Int J Antimicrob Agents. 2023 Nov;62(5):106985. doi: 10.1016/j.ijantimicag.2023.106985. Epub 2023 Sep 27.

Abstract

Acquired β-lactamase-encoding genes are typically carried by large plasmids in Gram-negative bacteria, which also commonly carry multi-copy small plasmids. This study found that mobile genetic elements carrying antimicrobial resistance genes are capable of hijacking small plasmids. This study focused on aztreonam-avibactam (ATM-AVI) as this combination can be used to effectively counter almost all β-lactamases produced by bacteria, and has been recommended against carbapenem-resistant Enterobacterales. A clinical strain (085003) of carbapenem-resistant Escherichia coli was investigated, and mutants (085003R32 and 085003R512) able to grow under 32/4 and 512/4 mg/L of ATM-AVI were obtained as representatives of low- and high-level resistance, respectively, by induction. Comparative genomics showed that 085003R32 and 085003R512 had a single nucleotide mutation of β-lactamase gene blaCMY-2, encoding a novel CMY with a Thr319Ile substitution, assigned 'CMY-2R'. Cloning and enzyme kinetics were used to verify that CMY-2R conferred ATM-AVI resistance by compromising binding of AVI and subsequent protection of ATM. Mechanisms for the discrepant resistance between 085003R32 and 085003R512 were investigated. Three tandem copies of blaCMY-2R were identified on a self-transmissible IncP1 plasmid of 085003R32 due to IS1294 misrecognizing its end terIS and rolling-circle replication. 085003R512 had only a single copy of blaCMY-2R on the IncP1 plasmid, but possessed anther blaCMY-2R on an already present 4-kb small plasmid. IS1294-mediated mobilization on to this multi-copy small plasmid increased the copy number of blaCMY-2R significantly, rendering higher resistance. This study shows that bacteria can employ multiple approaches to accommodate selection pressures imposed by exposure to varied concentrations of antimicrobial agents.

Keywords: Antimicrobial resistance; Avibactam; Aztreonam; Carbapenem resistance; Enterobacterales; Fitness cost; IS1294; Multi-copy plasmids; Small plasmids.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Azabicyclo Compounds / pharmacology
  • Aztreonam* / pharmacology
  • Carbapenems
  • Ceftazidime* / pharmacology
  • Drug Combinations
  • Escherichia coli / metabolism
  • Microbial Sensitivity Tests
  • Plasmids / genetics
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism

Substances

  • avibactam, ceftazidime drug combination
  • Aztreonam
  • avibactam
  • Ceftazidime
  • Azabicyclo Compounds
  • Drug Combinations
  • beta-Lactamases
  • Carbapenems
  • Anti-Bacterial Agents